We are trusted partners to our founders and co-investors. We use our deep scientific and industry networks to create exceptional value and shared success.
Leeds, UK, 5 February 2021: LUNAC Therapeutics (LUNAC), a UK based drug discovery company focused on the development of advanced life-saving anticoagulants, has been named as this year’s Start... CHARLOTTESVILLE, Va. —Slate Bio, Inc., announced today the closing of a $1.75 million venture financing. Epidarex Capital led the investment round with participation from the UVA Licensing &...
LUNAC Therapeutics Wins Start Up of the Year at Bionow Awards
Slate Bio Launches with Seed Financing to Develop Next Generation IL-2 Therapies